Your browser is no longer supported. Please, upgrade your browser.
ABBV AbbVie Inc. daily Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E18.72 EPS (ttm)4.55 Insider Own0.10% Shs Outstand1.76B Perf Week0.90%
Market Cap150.13B Forward P/E7.03 EPS next Y12.10 Insider Trans-5.15% Shs Float1.76B Perf Month-2.34%
Income6.91B PEG2.00 EPS next Q2.77 Inst Own70.90% Short Float0.73% Perf Quarter-11.30%
Sales36.23B P/S4.14 EPS this Y42.30% Inst Trans0.11% Short Ratio1.76 Perf Half Y3.96%
Book/sh8.93 P/B9.53 EPS next Y16.09% ROA7.10% Target Price109.12 Perf Year6.98%
Cash/sh3.42 P/C24.86 EPS next 5Y9.38% ROE-303.40% 52W Range62.55 - 101.28 Perf YTD-3.89%
Dividend4.72 P/FCF20.25 EPS past 5Y36.80% ROI21.20% 52W High-15.98% Beta0.67
Dividend %5.55% Quick Ratio0.70 Sales past 5Y10.80% Gross Margin73.30% 52W Low36.05% ATR2.01
Employees47000 Current Ratio0.90 Sales Q/Q26.30% Oper. Margin30.20% RSI (14)47.70 Volatility2.57% 1.99%
OptionableYes Debt/Eq5.94 EPS Q/Q-192.90% Profit Margin19.10% Rel Volume2.45 Prev Close80.67
ShortableYes LT Debt/Eq5.58 EarningsOct 30 BMO Payout98.80% Avg Volume7.34M Price85.10
Recom2.00 SMA20-0.10% SMA50-3.92% SMA200-4.13% Volume18,003,710 Change5.49%
Sep-29-20Initiated Berenberg Hold $98
Jun-23-20Upgrade Atlantic Equities Neutral → Overweight $115
Jun-09-20Upgrade Wolfe Research Peer Perform → Outperform
Jun-02-20Upgrade Argus Hold → Buy $115
May-18-20Resumed BofA/Merrill Neutral $95
May-12-20Upgrade JP Morgan Neutral → Overweight $105
May-11-20Resumed Morgan Stanley Overweight $95
Apr-20-20Upgrade RBC Capital Mkts Sector Perform → Outperform $79 → $93
Mar-23-20Downgrade Societe Generale Buy → Hold
Feb-27-20Initiated Barclays Equal Weight $97
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Oct-30-20 04:30PM  
02:18PM  
12:15PM  
11:45AM  
09:42AM  
09:05AM  
08:13AM  
08:05AM  
07:53AM  
07:47AM  
07:47AM  
07:15AM  
07:00AM  
Oct-29-20 10:04AM  
07:30AM  
02:05AM  
Oct-28-20 06:51PM  
04:48PM  
12:08PM  
08:31AM  
08:00AM  
Oct-27-20 06:12AM  
Oct-26-20 05:45PM  
07:11AM  
Oct-23-20 12:30PM  
10:48AM  
10:05AM  
Oct-22-20 10:15AM  
Oct-21-20 11:45AM  
Oct-20-20 05:45PM  
11:52AM  
03:46AM  
Oct-19-20 06:55PM  
10:06AM  
09:27AM  
08:56AM  
Oct-17-20 06:50AM  
Oct-16-20 07:34PM  
11:04AM  
07:57AM  
05:16AM  
Oct-15-20 04:25PM  
01:34PM  
Oct-14-20 06:55AM  
Oct-13-20 05:45PM  
01:22PM  
12:48PM  
11:35AM  
Oct-09-20 06:14PM  
05:16PM  
02:02PM  
09:26AM  
09:00AM  
Oct-07-20 05:45PM  
03:28PM  
08:00AM  
Oct-06-20 08:00AM  
Oct-05-20 11:45AM  
06:00AM  
Oct-04-20 06:43AM  
Oct-02-20 03:21PM  
08:30AM  
Oct-01-20 01:55PM  
09:23AM  
06:01AM  
Sep-30-20 09:32AM  
09:15AM  
Sep-29-20 10:52AM  
Sep-28-20 05:45PM  
08:00AM  
07:23AM  
Sep-26-20 06:37AM  
Sep-24-20 07:53AM  
Sep-22-20 08:59AM  
Sep-21-20 05:45PM  
08:00AM  
Sep-18-20 01:13PM  
06:10AM  
06:04AM  
Sep-17-20 11:45AM  
10:00AM  
06:47AM  
Sep-16-20 08:00AM  
Sep-15-20 08:00PM  
04:53PM  
Sep-14-20 05:45PM  
08:00AM  
Sep-13-20 08:00PM  
02:43PM  
02:00PM  
Sep-12-20 08:30AM  
Sep-11-20 08:26PM  
11:30AM  
10:20AM  
09:39AM  
09:14AM  
06:40AM  
06:30AM  
Sep-10-20 01:52PM  
Sep-09-20 07:35PM  
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALBAN CARLOSVice ChairmanJul 07Sale100.0053,3255,332,555114,899Jul 08 09:19 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsMay 12Sale90.0023,0242,072,21152,760May 12 05:44 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerMay 05Sale85.0019,4451,652,8250May 07 05:01 PM
Durkin Brian LVP, ControllerMar 30Buy69.0075051,75016,844Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 20Buy67.5080054,00016,094Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 18Buy68.182,200150,00515,294Mar 20 04:56 PM
RAPP EDWARD JDirectorMar 03Buy87.872,875252,6172,875Mar 04 05:14 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.